Empowering Complex Early Phase Trials: How MAC Clinical Research Innovates With Medrio CDMS/EDC

Selecting the right technology provider for early phase clinical trials is increasingly challenging amid evolving regulatory requirements and complex protocols. MAC Clinical Research, a leading Contract Research Organization (CRO) in Europe, specializing in global clinical trials, faced this challenge. Known for excelling in first-in-human (FIH) and early phase trials, particularly in central nervous system (CNS) disorders, dementia, and pain research, MAC sought a reliable technology partner.

MAC chose Medrio as its exclusive CDMS/EDC provider for clinical trials, leveraging standard libraries to streamline the study build process. Despite trial complexities, they aimed for a 12-week build time. In an interview with Hannah Gillis, Head of Data Management at MAC Clinical Research, Gills explained how Medrio was able to support their trials through expert guidance and upholding complex protocols, which ultimately accelerated study timelines. Access the case study below to see how the partnership between MAC Clinical Research and Medrio also highlights the critical role of technology in navigating the challenges of early phase clinical trials.